2016 American Transplant Congress

Monday, June 13, 2016

5:18pm-5:30pm

Impact of Early Hospital Readmission Following Simultaneous Pancreas Kidney Transplantation.

E. King, L. Kucirka, M. McAdams-DeMarco, M. Bowring, A. Massie, D. Segev.

Concurrent Session: Clinical Pancreas Transplantation 1  •  Room 309

5:18pm-5:30pm

Incidence & Impact of De Novo DSA (dnDSA) Formation on Transplant Outcomes in HLA-Sensitized (HS) Patients Transplanted After IVG+Rituximab Desensitization (DES).

A. Vo,¹ J. Choi,¹ J. Kahwaji,¹ J. Mirocha,² A. Peng,¹ R. Villicana,¹ S. Jordan.¹

Concurrent Session: Kidney: Desensitization  •  Room 304

5:18pm-5:30pm

Natural History of Response to Wounding in Human Kidney Transplants.

K. Famulski,¹ J. Venner,^2,1 J. Reeve,¹ P. Halloran.¹

Concurrent Session: Kidney Transplant Recipient: Long Term Outcomes Session I  •  Veterans Auditorium

5:18pm-5:30pm

Porcine Islets Engineered to Display SA-FasL Protein on Their Surface Induce Tolerance in Mice Following Transplantation into the Liver or Under the Kidney Capsule.

H. Zhao,¹ K. Woodward,¹ H. Shirwan,¹ M. Graham,² B. Hering,² E. Yolcu.¹

Concurrent Session: Xenotransplantation: Animal Models  •  Room 102

5:18pm-5:30pm

Probability, Risk Factors, and Long-Term Outcomes of Biliary Complications After Hepatic Artery Thrombosis in Adult Liver Transplant Recipients: 20 Years Experience from a Single Center.

M. Fujiki, K. Hashimoto, T. Diago, C. Quintini, F. Aucejo, D. Kelly, B. Eghtesad, J. Fung, C. Miller.

Concurrent Session: Liver Transplantation Peri-Operative Considerations  •  Room 311

5:18pm-5:30pm

The 20S Proteasome, Active within Exosome-Like Vesicles Released by Apoptotic Cells Accelerates Rejection.

M. Dieudé,^1,4,5 C. Bell,^2,5 J. Turgeon,^1,5 D. Beillevaire,^1,4,5 S. Qi,^1,5 E. Boilard,^3,5 P. Thibault,^2,5 M.-J. Hébert.^1,4,5

Concurrent Session: Pathways of Allograft Rejection: Animal Models  •  Room 310

5:18pm-5:30pm

The Medication Level Variability Index (MLVI), a Behavioral Biomarker, Predicts Late Allograft Rejection in Pediatric Liver Transplant Recipients – A Prospective Multisite Study.

E. Shemesh,¹ J. Bucuvalas,² R. Anand,³ R. Venick,⁴ E. Alonso,⁵ J. Mitchell,³ R. Annunziato,¹ G. Mazariegos,⁶ B. Shneider.⁷

Concurrent Session: Pediatric Liver Transplant  •  Room 206

5:18pm-5:30pm

Variation in Co-Medication Use According to Kidney Transplant Immunosuppressive Regimen: Application of Integrated Registry and Pharmacy Claims Data.

K. Lentine,¹ A. Naik,² M. Schnitzler,¹ D. Axelrod,³ J. Chen,¹ D. Brennan,⁴ D. Segev,⁵ B. Kasiske,⁶ H. Randall,¹ V. Dharnidharka.⁴

Concurrent Session: Medication Errors, Variability and Adherence  •  Room 302

5:30pm-5:42pm

Abrogating Donor-Derived Myd88 Signaling Impairs the Recruitment of Recipient Neutrophils and CD8 T Cells into Lung Allografts in Mice.

Z. Zheng,¹ J.-J. Wang,¹ X. Yeap,¹ X. Kang,¹ Y. Xie,¹ X. Luo,² Z. Zhang.¹

Concurrent Session: Challenges to Graft Survival and Tolerance: Animal Models  •  Room 306

5:30pm-5:42pm

Association of Cytomegalovirus-Specific T Cell-Mediated Immunity with the Risk of CMV Infection Occurrence in Kidney Transplant Recipients.

D. Dęborska-Materkowska,¹ A. Perkowska-Ptasińska,¹ A. Sadowska,¹ D. Sitarek,¹ J. Gozdowska,¹ M. Ciszek,² M. Serwańska-Świętek,³ A. Jóźwik,³ P. Domagała,³ A. Kwiatkowski,³ M. Durlik.¹

Concurrent Session: CMV: Immune Monitoring & MicroRNA Responses  •  Room 306